bioMérieux S.A. (BMXMF)
OTCMKTS · Delayed Price · Currency is USD
135.01
0.00 (0.00%)
Sep 29, 2025, 8:00 PM EDT
bioMérieux Market Cap
bioMérieux has a market cap or net worth of $15.98 billion as of October 1, 2025. Its market cap has increased by 11.71% in one year.
Market Cap
15.98B
Enterprise Value
16.13B
Revenue
4.84B
Ranking
n/a
PE Ratio
36.01
Stock Price
$135.01
Market Cap Chart
Since July 7, 2004, bioMérieux's market cap has increased from 1.46B to 15.98B, an increase of 991.72%. That is a compound annual growth rate of 11.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2025 | 15.98B | 26.39% |
| Dec 31, 2024 | 12.64B | -3.73% |
| Dec 29, 2023 | 13.14B | 6.03% |
| Dec 30, 2022 | 12.39B | -26.30% |
| Dec 31, 2021 | 16.81B | 0.64% |
| Dec 31, 2020 | 16.70B | 58.81% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 789.71M |
| Elite Pharmaceuticals | 742.59M |
| Tian'an Technology Group | 718.73M |
| Glass House Brands | 516.60M |
| Northwest Biotherapeutics | 387.17M |
| CytoDyn | 332.57M |
| American Oncology Network | 305.31M |
| Nika Pharmaceuticals | 301.74M |